Product Information
SEMGLEE (YFGN) 100 UNIT/ML VL is a brand biologic product labeled by Biocon Biologics Inc., priced at $26.0674 per ML under NDC 83257001111. Its NADAC has been published 129 times since Apr 17, 2024.
Strength
100 [iU]/mL
Manufacturer
Biocon Biologics Inc.NDC
83257001111
Classification
Brand Biologic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN GLARGINEApproval Type
Biologic (BLA)
FDA Application
BLA761201On Market Since
7/28/2023
Pharmacological Classes
Price Statistics
The NADAC for SEMGLEE (YFGN) 100 UNIT/ML VL has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.0674 per ML |
|---|---|
| All-time high | $26.0674 (Sep 30, 2026) |
| All-time low | $25.8811 (Feb 18, 2026) |
| 52-week high | $26.0674 |
| 52-week low | $25.8811 |
| Median price | $25.8976 |
| Average price | $25.9090 |
| Largest weekly change | +0.3% (Sep 23, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Biologics Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin glargine-yfgn market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SEMGLEE (YFGN) 100 UNIT/ML VL?
The current National Average Drug Acquisition Cost (NADAC) for SEMGLEE (YFGN) 100 UNIT/ML VL, manufactured by Biocon Biologics Inc., is $26.0674 per ML (NDC 83257001111), effective Sep 30, 2026.
How has the price of SEMGLEE (YFGN) 100 UNIT/ML VL changed over time?
Over the history we have for it, the NADAC for SEMGLEE (YFGN) 100 UNIT/ML VL has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SEMGLEE (YFGN) 100 UNIT/ML VL?
Since Apr 17, 2024, the NADAC for SEMGLEE (YFGN) 100 UNIT/ML VL has ranged from a low of $25.8811 (Feb 18, 2026) to a high of $26.0674 (Sep 30, 2026), with a median of $25.8976 per ML.
Are there cheaper alternatives to SEMGLEE (YFGN) 100 UNIT/ML VL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SEMGLEE (YFGN) 100 UNIT/ML PEN, is $25.7546 per ML — about 1% below SEMGLEE (YFGN) 100 UNIT/ML VL.
Who manufactures SEMGLEE (YFGN) 100 UNIT/ML VL?
SEMGLEE (YFGN) 100 UNIT/ML VL (NDC 83257001111) is labeled by Biocon Biologics Inc., and CMS classifies it as a brand biologic product.